Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q1 2023 call → NOThe question asks whether management describes that the company's successive engagements of the same kind are coming in at progressively larger size — that is, whether the deals/contracts/projects/customers/sites/programs it is landing now are individually bigger, broader, or longer than before for the same offering. Let me scan the transcript for any such description. The transcript discusses: - Occupancy growth, leasing spreads, rent growth - Reinvestment pipeline ($360 million at 9% incremental return) - Dispositions of $125 million of non-core assets - Bed Bath recaptures, leasing to Sprouts and HomeGoods - Signed but not commenced pipeline of $56 million ABR - Strong demand from retailers I need to look for any statement that the size of individual deals, contracts, projects, or programs is escalating — that each new instance is bigger than the last. Looking through the transcript... I see discussion of: - Leasing spreads (43% new, 14% renewal) — these are rent increases, not deal size increases - Occupancy at record levels - Reinvestment pipeline at $360 million - The $885 million delivered at 11% incremental return There's no statement about deals, orders, contracts, projects, customers, sites, or programs coming in at progressively larger size. The discussion is about rent growth, occupancy growth, and volume of leasing activity, but not about the individual size of engagements escalating. The question is specifically about whether the unit size of the company's repeatable business is escalating. Nothing in the transcript suggests that, for example, new leases are for larger spaces, or that new projects are bigger than past projects, or that new customers are starting at larger scale. The transcript talks about strong demand, record occupancy, rent spreads — but these are about pricing and volume, not about the size of individual engagements growing. So the answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.